Clinical trial Recruiting at 1 site Observational Ages 18 and up

Can Cardiac Cycle Efficiency predict high-dose vasoactive-inotropic needs after open-heart surgery?

Official title: The Value of Cardiac Cycle Efficiency After Cardiopulmonary Bypass in Predicting Vasoactive-Inotropic Support Requirement (VIS) in the First 24 Hours in Open-Heart Surgery: A Prospective Observational Cohort Study

Run by Bursa City Hospital · NCT07926360 · Data updated 2026-11-12

This study tests whether Cardiac Cycle Efficiency measured after coming off bypass can predict which adults will need high doses of vasoactive and inotropic meds in the first 24 hours after open-heart surgery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment68 (estimated)
SponsorBursa City Hospital
Government
Locations1 site (Nilufer, Bursa)
StatusRecruiting
StartedNovember 1, 2026
Main results expectedJanuary 15, 2027
Study endsJanuary 15, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT07926360 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older undergoing elective CABG, valve surgery, or combined CABG and valve surgery with CPB, who can consent and have reliable arterial monitoring.

Probably not a fit

Patients with unstable arterial waveforms, emergency surgeries, or those needing immediate circulatory support may not benefit from this marker's predictive value.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center prospective observational study will analyze hemodynamic data collected from arterial lines at six perioperative time points after cardiopulmonary bypass. Cardiac Cycle Efficiency (CCE) is derived from arterial waveform analysis using MostCare Up and will be evaluated for its ability to predict a maximum VIS of 15 or higher within 24 hours postoperatively. The predictive performance will be assessed with ROC analysis, and associations with lactate levels, duration of mechanical ventilation, ICU/hospital stay, acute kidney injury, and in-hospital mortality will be explored. No additional procedures will be performed beyond routine care, and data come from standard arterial monitoring. The goal is to identify early markers of patients at risk for significant vasopressor/inotrope support.

Why it matters

Potential benefit: If successful, CCE could help clinicians identify patients at risk for high inotropic/vasoactive needs early after surgery, enabling more timely management.

How similar studies have gone: Prior findings in children suggest CCE relates to inotropic needs; applicability in adults remains to be proven, making this approach exploratory in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* ASA physical status II-IV
* Elective coronary artery bypass grafting, valve surgery, or combined CABG and valve surgery with cardiopulmonary bypass
* Written informed consent

Exclusion Criteria:

* Emergency surgery
* Preoperative mechanical circulatory support (IABP, ECMO, Impella, etc.)
* Permanent pacemaker dependency
* Severe arrhythmia (uncontrolled atrial fibrillation, ventricular arrhythmia, etc.)
* Redo cardiac surgery
* Aortic dissection
* Pregnancy
* Unreliable arterial pressure waveform
* Need for IABP, ECMO, or temporary epicardial pacing during weaning from bypass or during surgery

Where it's running

  • Bursa City Hospital
    Nilufer, Bursa, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.